DE NOVO TUBERCULOSIS DURING ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY IN A RHEUMATOID ARTHRITIS PATIENT WITH NEGATIVE INITIAL SCREENING

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MOBINI MARYAM; NIKSOLAT FATEMEH; GHASEMIAN ROYA; SHARIFPOUR ALI; VALIPOUR SARA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Mazandaran University of Medical Sciences Year:2017 | Volume:26 | Issue:144 Page(s): 382-388

Download Full-Text

Persian Verion

View:

678

Download:

Cites:

Information Journal Paper

Title

DE NOVO TUBERCULOSIS DURING ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY IN A RHEUMATOID ARTHRITIS PATIENT WITH NEGATIVE INITIAL SCREENING

Author(s)

Keywords

TUBERCULOSISQ3

INFLIXIMABQ1

RHEUMATOID ARTHRITISQ2

Abstract

TUBERCULOSIS is a major concern in patients with rheumatologic disorders under immunosuppressive therapy. In this paper a 67-year old woman is presented with seropositive RHEUMATOID ARTHRITIS and negative screening for latent TUBERCULOSIS. She was treated with INFLIXIMAB since 22 months ago. She developed constitutional and respiratory manifestations and flare of articular symptoms during treatment by immunosuppressive agents. TUBERCULOSIS clinical presentation and investigation tests including imaging, pleural effusion analysis and interferon g release assay (IGRA) estimation and anti-TUBERCULOSIS treatment was initiated and dose of prednisolone was increased. Afterwards, constitutional respiratory and articular signs improved significantly. Beside of initial screening, attention to TUBERCULOSIS in patients being treated with biologic drugs should be done at any time.

Cites

No record.

References

No record.

Cite

APA: Copy

MOBINI, MARYAM, NIKSOLAT, FATEMEH, GHASEMIAN, ROYA, SHARIFPOUR, ALI, & VALIPOUR, SARA. (2017). DE NOVO TUBERCULOSIS DURING ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY IN A RHEUMATOID ARTHRITIS PATIENT WITH NEGATIVE INITIAL SCREENING. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, 26(144), 382-388. SID. https://sid.ir/paper/45380/en

Vancouver: Copy

MOBINI MARYAM, NIKSOLAT FATEMEH, GHASEMIAN ROYA, SHARIFPOUR ALI, VALIPOUR SARA. DE NOVO TUBERCULOSIS DURING ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY IN A RHEUMATOID ARTHRITIS PATIENT WITH NEGATIVE INITIAL SCREENING. JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES[Internet]. 2017;26(144):382-388. Available from: https://sid.ir/paper/45380/en

IEEE: Copy

MARYAM MOBINI, FATEMEH NIKSOLAT, ROYA GHASEMIAN, ALI SHARIFPOUR, and SARA VALIPOUR, “DE NOVO TUBERCULOSIS DURING ANTI-TUMOR NECROSIS FACTOR-ALPHA THERAPY IN A RHEUMATOID ARTHRITIS PATIENT WITH NEGATIVE INITIAL SCREENING,” JOURNAL OF MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES, vol. 26, no. 144, pp. 382–388, 2017, [Online]. Available: https://sid.ir/paper/45380/en

Related Journal Papers